-       Clinical Trials 
   - April 2025
    -  40 Pages 
    Global
   
   From       €897EUR$1,000USD£788GBP 
      €1122EUR$1,250USD£984GBP 
                  -       Report 
   - June 2024
    -  200 Pages 
    Global
   
   From       €5707EUR$6,360USD£5,009GBP 
      €7134EUR$7,950USD£6,261GBP 
                  -       Report 
   - May 2024
    -  131 Pages 
    Global
   
   From       €4957EUR$5,524USD£4,351GBP 
      €5832EUR$6,499USD£5,118GBP 
                      Endocarditis is a type of cardiovascular disease caused by an infection of the inner lining of the heart. Endocarditis drugs are used to treat this condition and can be divided into two categories: antibiotics and antifungal medications. Antibiotics are used to treat bacterial infections, while antifungal medications are used to treat fungal infections. These drugs are typically administered intravenously or orally, depending on the severity of the infection.
Endocarditis drugs are used to reduce    the risk of complications associated with the disease, such as heart valve damage, stroke, and heart failure. They can also help to reduce the risk of recurrence of the infection.
Some of the companies in the endocarditis drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. These companies are involved in the development, manufacture, and marketing of endocarditis drugs. Show Less   Read more